Adial Pharmaceuticals, Inc.
About
Adial is focused on developing therapies for the treatment and prevention of addiction and related disorders. Our lead investigational drug candidate, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD).
Contact
Dick Leary
Phone Number
(434) 422-9800Sector
Therapeutics
Company Stage
Development
Funding Sources
- Grants
- Private Investment
- Publicly Traded
Company Size
9
Facility Size
4200 sq ft
Address
1180 Seminole Trail
Charlottesville, VA 22901
Charlottesville, VA 22901